Massachusetts | 04-2713778 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Yes X | No |
Yes X | No |
Large accelerated filer
|
X | Accelerated filer | ||||
Non-accelerated filer
|
Smaller reporting company |
Yes | No X |
2
Three-months Ended | Six-months Ended | |||||||||||||||
July 3, | July 4, | July 3, | July 4, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Revenue |
||||||||||||||||
Product |
$ | 77,566 | $ | 67,067 | $ | 146,443 | $ | 121,680 | ||||||||
Service |
5,827 | 4,744 | 11,344 | 9,098 | ||||||||||||
83,393 | 71,811 | 157,787 | 130,778 | |||||||||||||
Cost of revenue |
||||||||||||||||
Product |
16,454 | 15,914 | 31,553 | 28,825 | ||||||||||||
Service |
2,925 | 2,803 | 6,209 | 5,833 | ||||||||||||
19,379 | 18,717 | 37,762 | 34,658 | |||||||||||||
Gross margin |
||||||||||||||||
Product |
61,112 | 51,153 | 114,890 | 92,855 | ||||||||||||
Service |
2,902 | 1,941 | 5,135 | 3,265 | ||||||||||||
64,014 | 53,094 | 120,025 | 96,120 | |||||||||||||
Research, development, and engineering expenses |
10,506 | 8,076 | 19,988 | 16,179 | ||||||||||||
Selling, general, and administrative expenses |
29,466 | 25,738 | 58,627 | 49,360 | ||||||||||||
Restructuring charges |
- | 39 | - | 88 | ||||||||||||
Operating income |
24,042 | 19,241 | 41,410 | 30,493 | ||||||||||||
Foreign currency gain (loss) |
210 | (8 | ) | 151 | (173 | ) | ||||||||||
Investment income |
697 | 308 | 1,302 | 565 | ||||||||||||
Other expense |
(148 | ) | (156 | ) | (353 | ) | (402 | ) | ||||||||
Income before income tax expense |
24,801 | 19,385 | 42,510 | 30,483 | ||||||||||||
Income tax expense |
5,704 | 4,458 | 9,777 | 7,011 | ||||||||||||
Net income |
$ | 19,097 | $ | 14,927 | $ | 32,733 | $ | 23,472 | ||||||||
Earnings per weighted-average common and common-equivalent share: |
||||||||||||||||
Basic |
$ | 0.46 | $ | 0.38 | $ | 0.79 | $ | 0.59 | ||||||||
Diluted |
$ | 0.45 | $ | 0.38 | $ | 0.77 | $ | 0.59 | ||||||||
Weighted-average common and common-equivalent shares outstanding: |
||||||||||||||||
Basic |
41,842 | 39,683 | 41,586 | 39,675 | ||||||||||||
Diluted |
42,810 | 39,793 | 42,532 | 39,736 | ||||||||||||
Cash dividends per common share |
$ | 0.09 | $ | 0.06 | $ | 0.17 | $ | 0.11 | ||||||||
3
July 3, | December 31, | |||||||
2011 | 2010 | |||||||
(unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 42,676 | $ | 33,203 | ||||
Short-term investments |
202,012 | 147,823 | ||||||
Accounts receivable, less reserves of $1,248 and $1,235 in 2011 and 2010, respectively |
42,480 | 45,901 | ||||||
Inventories |
27,004 | 22,717 | ||||||
Deferred income taxes |
6,319 | 6,302 | ||||||
Prepaid expenses and other current assets |
21,810 | 23,059 | ||||||
Total current assets |
342,301 | 279,005 | ||||||
Long-term investments |
108,700 | 102,055 | ||||||
Property, plant, and equipment, net |
30,590 | 29,596 | ||||||
Deferred income taxes |
15,707 | 15,555 | ||||||
Intangible assets, net |
21,047 | 23,130 | ||||||
Goodwill |
82,654 | 82,204 | ||||||
Other assets |
1,658 | 1,559 | ||||||
$ | 602,657 | $ | 533,104 | |||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 6,922 | $ | 7,153 | ||||
Accrued expenses |
27,941 | 29,346 | ||||||
Accrued income taxes |
8,726 | 7,771 | ||||||
Deferred revenue and customer deposits |
13,089 | 10,162 | ||||||
Total current liabilities |
56,678 | 54,432 | ||||||
Reserve for income taxes |
5,694 | 5,361 | ||||||
Commitments and contingencies (Note 8) |
||||||||
Shareholders equity: |
||||||||
Common stock, $.002 par value
Authorized: 140,000 shares, issued: 42,065 and 41,065 shares in 2011 and 2010, respectively |
84 | 82 | ||||||
Additional paid-in capital |
130,171 | 102,620 | ||||||
Retained earnings |
405,463 | 379,826 | ||||||
Accumulated other comprehensive gain (loss), net of tax |
4,567 | (9,217 | ) | |||||
Total shareholders equity |
540,285 | 473,311 | ||||||
$ | 602,657 | $ | 533,104 | |||||
4
Accumulated | ||||||||||||||||||||||||||||
Additional | Other | Total | ||||||||||||||||||||||||||
Common Stock | Paid-in | Retained | Comprehensive | Comprehensive | Shareholders | |||||||||||||||||||||||
Shares | Par Value | Capital | Earnings | Gain (Loss) | Income | Equity | ||||||||||||||||||||||
Balance as of December 31, 2010 |
41,065 | $ 82 | $ 102,620 | $ 379,826 | $ (9,217 | ) | $ 473,311 | |||||||||||||||||||||
Issuance of common stock under stock option plans |
1,000 | 2 | 20,817 | - | - | 20,819 | ||||||||||||||||||||||
Stock-based compensation expense |
- | - | 4,309 | - | - | 4,309 | ||||||||||||||||||||||
Excess tax benefit from stock option exercises |
- | - | 2,425 | - | - | 2,425 | ||||||||||||||||||||||
Payment of dividends |
- | - | - | (7,096) | - | (7,096) | ||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||
Net income |
- | - | - | 32,733 | - | $ 32,733 | 32,733 | |||||||||||||||||||||
Net unrealized loss on available-for-sale investments, net of tax of $35 |
- | - | - | - | (177) | (177) | (177) | |||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $469 |
- | - | - | - | 13,961 | 13,961 | 13,961 | |||||||||||||||||||||
Comprehensive income |
$ 46,517 | |||||||||||||||||||||||||||
Balance as of July 3, 2011 (unaudited) |
42,065 | $ 84 | $ 130,171 | $ 405,463 | $ 4,567 | $ 540,285 | ||||||||||||||||||||||
5
Six-Months Ended | ||||||||
July 3, | July 4, | |||||||
2011 | 2010 | |||||||
(unaudited) | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 32,733 | $ | 23,472 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Stock-based compensation expense |
4,309 | 394 | ||||||
Depreciation of property, plant, and equipment |
2,669 | 2,282 | ||||||
Amortization of intangible assets |
2,130 | 2,462 | ||||||
Amortization of premiums/discounts on investments |
2,996 | 1,091 | ||||||
Tax effect of stock option exercises |
(2,425) | 76 | ||||||
Change in deferred income taxes |
(642) | (789) | ||||||
Change in operating assets and liabilities |
6,309 | (7,711) | ||||||
Net cash provided by operating activities |
48,079 | 21,277 | ||||||
Cash flows from investing activities: |
||||||||
Purchases of investments |
(168,165) | (116,600) | ||||||
Maturities and sale of investments |
114,803 | 35,486 | ||||||
Purchases of property, plant, and equipment |
(3,625) | (2,231) | ||||||
Cash received related to disposition |
- | 315 | ||||||
Net cash used in investing activities |
(56,987) | (83,030) | ||||||
Cash flows from financing activities: |
||||||||
Issuance of common stock under stock option plans |
20,819 | 395 | ||||||
Stock option buyback |
- | (83) | ||||||
Payment of dividends |
(7,096) | (4,365) | ||||||
Tax effect of stock option exercises |
2,425 | (76) | ||||||
Net cash provided by (used in) financing activities |
16,148 | (4,129) | ||||||
Effect of foreign exchange rate changes on cash |
2,233 | (16,007) | ||||||
Net increase (decrease) in cash and cash equivalents |
9,473 | (81,889) | ||||||
Cash and cash equivalents at beginning of period |
33,203 | 119,831 | ||||||
Cash and cash equivalents at end of period |
$ | 42,676 | $ | 37,942 | ||||
6
7
Quoted Prices in | ||||||||
Active Markets | Significant Other | |||||||
for Identical | Observable | |||||||
Assets (Level 1) | Inputs (Level 2) | |||||||
Assets: |
||||||||
Money market instruments |
$ | 2,452 | $ | - | ||||
Treasury bills |
- | 25,215 | ||||||
Municipal bonds |
- | 118,703 | ||||||
Corporate bonds |
- | 105,744 | ||||||
Agency bonds |
- | 38,416 | ||||||
Sovereign bonds |
- | 21,531 | ||||||
Covered bonds |
- | 6,715 | ||||||
Currency forward contracts |
209 | - | ||||||
Liabilities: |
||||||||
Currency forward contracts |
13 | - |
8
July 3, | December 31, | |||||||
2011 | 2010 | |||||||
Cash |
$ | 28,679 | $ | 26,650 | ||||
Money market instruments |
2,452 | 6,553 | ||||||
Treasury bills |
11,545 | - | ||||||
Cash and cash equivalents |
42,676 | 33,203 | ||||||
Treasury bills |
12,979 | 2,494 | ||||||
Municipal bonds |
86,029 | 75,457 | ||||||
Corporate bonds |
68,425 | 34,543 | ||||||
Agency bonds |
23,428 | 15,979 | ||||||
Sovereign bonds |
11,151 | 19,350 | ||||||
Short-term investments |
202,012 | 147,823 | ||||||
Treasury bills |
691 | - | ||||||
Municipal bonds |
32,674 | 34,794 | ||||||
Corporate bonds |
37,319 | 36,762 | ||||||
Agency bonds |
14,988 | 21,025 | ||||||
Sovereign bonds |
10,380 | - | ||||||
Covered bonds |
6,715 | 3,541 | ||||||
Limited partnership interest (accounted for using cost method) |
5,933 | 5,933 | ||||||
Long-term investments |
108,700 | 102,055 | ||||||
$ | 353,388 | $ | 283,081 | |||||
9
Gross | Gross | |||||||||||||||
Amortized | Unrealized | Unrealized | ||||||||||||||
Cost | Gains | Losses | Fair Value | |||||||||||||
Short-term: |
||||||||||||||||
Treasury bills |
$ | 12,979 | $ | - | $ | - | $ | 12,979 | ||||||||
Municipal bonds |
85,959 | 75 | (5) | 86,029 | ||||||||||||
Corporate bonds |
68,528 | 15 | (118) | 68,425 | ||||||||||||
Agency bonds |
23,442 | 24 | (38) | 23,428 | ||||||||||||
Sovereign bonds |
11,186 | - | (35) | 11,151 | ||||||||||||
Long-term: |
||||||||||||||||
Treasury bills |
690 | 1 | - | 691 | ||||||||||||
Municipal bonds |
32,549 | 127 | (2) | 32,674 | ||||||||||||
Corporate bonds |
37,732 | - | (413) | 37,319 | ||||||||||||
Agency bonds |
15,103 | 1 | (116) | 14,988 | ||||||||||||
Sovereign bonds |
10,387 | 2 | (9) | 10,380 | ||||||||||||
Covered bonds |
6,755 | - | (40) | 6,715 | ||||||||||||
$ | 305,310 | $ | 245 | $ | (776) | $ | 304,779 | |||||||||
Unrealized Loss Position For: | ||||||||||||||||||||||||
Less than 12 Months | 12 Months or Greater | Total | ||||||||||||||||||||||
Unrealized | Unrealized | Unrealized | ||||||||||||||||||||||
Fair Value | Losses | Fair Value | Losses | Fair Value | Losses | |||||||||||||||||||
Municipal bonds |
$ | 39,174 | $ | (7) | $ | - | $ | - | $ | 39,174 | $ | (7) | ||||||||||||
Corporate bonds |
84,990 | (515) | 10,438 | (16) | 95,428 | (531) | ||||||||||||||||||
Agency bonds |
24,993 | (149) | 1,259 | (5) | 26,252 | (154) | ||||||||||||||||||
Sovereign bonds |
13,144 | (23) | 2,483 | (21) | 15,627 | (44) | ||||||||||||||||||
Covered bonds |
6,715 | (40) | - | - | 6,715 | (40) | ||||||||||||||||||
$ | 169,016 | $ | (734) | $ | 14,180 | $ | (42) | $ | 183,196 | $ | (776) | |||||||||||||
<1 Year | 1-2 Years | 2-3 Years | 3-4 Years | Total | ||||||||||||||||
Treasury bills |
$ | 12,979 | $ | 691 | $ | - | $ | - | $ | 13,670 | ||||||||||
Municipal bonds |
86,029 | 23,889 | 7,769 | 1,016 | 118,703 | |||||||||||||||
Corporate bonds |
68,425 | 20,879 | 16,440 | - | 105,744 | |||||||||||||||
Agency bonds |
23,428 | 11,984 | 3,004 | - | 38,416 | |||||||||||||||
Sovereign bonds |
11,151 | 4,476 | 5,904 | - | 21,531 | |||||||||||||||
Covered bonds |
- | 6,715 | - | - | 6,715 | |||||||||||||||
$ | 202,012 | $ | 68,634 | $ | 33,117 | $ | 1,016 | $ | 304,779 | |||||||||||
10
July 3, | December 31, | |||||||
2011 | 2010 | |||||||
Raw materials |
$ | 17,877 | $ | 14,791 | ||||
Work-in-process |
2,765 | 2,051 | ||||||
Finished goods |
6,362 | 5,875 | ||||||
$ | 27,004 | $ | 22,717 | |||||
Balance as of December 31, 2010 |
$ | 1,985 | ||
Provisions for warranties issued during the period |
774 | |||
Fulfillment of warranty obligations |
(724) | |||
Foreign exchange rate changes |
137 | |||
Balance as of July 3, 2011 |
$ | 2,172 | ||
11
12
Currency | Amount | |
Japanese Yen/Euro
|
200,000,000 Japanese Yen | |
U.S. Dollar/Euro
|
14,310,000 U.S. Dollars |
Asset Derivatives | Liability Derivatives | |||||||||||||||||||
Fair Value | Fair Value | |||||||||||||||||||
Balance | Balance | |||||||||||||||||||
Sheet | July 3, | December 31, | Sheet | July 3, | December 31, | |||||||||||||||
Location | 2011 | 2010 | Location | 2011 | 2010 | |||||||||||||||
Currency forward contracts |
Prepaid
expenses and other current assets |
$ | 209 | $ | 83 | Accrued
expenses |
$ | 13 | $ | 125 |
Location of | Amount of Gain (Loss) | Location of | Amount of Gain (Loss) | |||||||||||||||||
Gain (Loss) | Recognized in Income on | Gain (Loss) | Recognized in Income on | |||||||||||||||||
Recognized | Derivatives | Recognized | Derivatives | |||||||||||||||||
in Income | Three-months ended | in Income | Six-months ended | |||||||||||||||||
on | July 3, | July 4, | on | July 3, | July 4, | |||||||||||||||
Derivatives | 2011 | 2010 | Derivatives | 2011 | 2010 | |||||||||||||||
Currency forward contracts |
Foreign
currency gain (loss) |
$ | 126 | $ | (206 | ) | Foreign
currency gain (loss) |
$ | 128 | $ | (274 | ) |
13
Weighted- | ||||||||||||||||
Weighted- | Average | Aggregate | ||||||||||||||
Average | Remaining | Intrinsic | ||||||||||||||
Shares | Exercise | Contractual | Value | |||||||||||||
(in thousands) | Price | Term (in years) | (in thousands) | |||||||||||||
Outstanding as of December 31, 2010 |
4,318 | $ | 20.05 | |||||||||||||
Granted |
927 | 30.40 | ||||||||||||||
Exercised |
(1,004) | 20.87 | ||||||||||||||
Forfeited or expired |
(52) | 22.00 | ||||||||||||||
Outstanding as of July 3, 2011 |
4,189 | $ 22.15 | 7.2 | $ 58,091 | ||||||||||||
Exercisable as of July 3, 2011 |
1,638 | $ 20.36 | 5.1 | $ 25,707 | ||||||||||||
Three-months Ended | Six-months Ended | |||||||||||||||
July 3, | July 4, | July 3, | July 4, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Risk-free rate |
3.6% | 3.2% | 3.6% | 3.4% | ||||||||||||
Expected dividend yield |
1.0% | 1.4% | 1.0% | 1.3% | ||||||||||||
Expected volatility |
42% | 44% | 42% | 44% | ||||||||||||
Expected term (in years) |
5.2 | 5.2 | 5.4 | 5.3 |
14
Three-months Ended | Six-months Ended | |||||||||||||||
July 3, | July 4, | July 3, | July 4, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Product cost of revenue |
$ 105 | $ 14 | $ 270 | $ 72 | ||||||||||||
Service cost of revenue |
39 | 11 | 109 | 12 | ||||||||||||
Research, development, and engineering |
529 | 83 | 1,338 | 334 | ||||||||||||
Selling, general, and administrative |
1,284 | 319 | 2,592 | (24) | ||||||||||||
$ | 1,957 | $ 427 | $ 4,309 | $ 394 | ||||||||||||
Three-months Ended | Six-months Ended | |||||||||||||||
July 3, | July 4, | July 3, | July 4, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Income tax at federal statutory rate |
35% | 35% | 35% | 35% | ||||||||||||
State income taxes, net of federal benefit |
1 | 1 | 1 | 1 | ||||||||||||
Foreign tax rate differential |
(13) | (13) | (13) | (13) | ||||||||||||
Income tax provision |
23% | 23% | 23% | 23% | ||||||||||||
15
Three-months Ended | Six-months Ended | |||||||||||||||
July 3, | July 4, | July 3, | July 4, | |||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Basic weighted-average common
shares outstanding |
41,842 | 39,683 | 41,586 | 39,675 | ||||||||||||
Effect of dilutive stock options |
968 | 110 | 946 | 61 | ||||||||||||
Weighted-average common and
common-equivalent shares outstanding |
42,810 | 39,793 | 42,532 | 39,736 | ||||||||||||
16
Three-months Ended | Reconciling | |||||||||||||||
July 3, 2011 | MVSD | SISD | Items | Consolidated | ||||||||||||
Product revenue |
$ | 70,942 | $ | 6,624 | $ | - | $ | 77,566 | ||||||||
Service revenue |
1,834 | 3,993 | - | 5,827 | ||||||||||||
Operating income |
26,587 | 2,022 | (4,567) | 24,042 |
Six-months Ended | Reconciling | |||||||||||||||
July 3, 2011 | MVSD | SISD | Items | Consolidated | ||||||||||||
Product revenue |
$ | 133,759 | $ | 12,684 | $ | - | $ | 146,443 | ||||||||
Service revenue |
3,803 | 7,541 | - | 11,344 | ||||||||||||
Operating income |
48,614 | 3,019 | (10,223) | 41,410 |
Three-months Ended | Reconciling | |||||||||||||||
July 4, 2010 | MVSD | SISD | Items | Consolidated | ||||||||||||
Product revenue |
$ | 59,345 | $ | 7,722 | $ | - | $ | 67,067 | ||||||||
Service revenue |
1,653 | 3,091 | - | 4,744 | ||||||||||||
Operating income |
22,939 | 1,330 | (5,028) | 19,241 |
Six-months Ended | Reconciling | |||||||||||||||
July 4, 2010 | MVSD | SISD | Items | Consolidated | ||||||||||||
Product revenue |
$ | 109,005 | $ | 12,675 | $ | - | $ | 121,680 | ||||||||
Service revenue |
3,150 | 5,948 | - | 9,098 | ||||||||||||
Operating income |
38,384 | 1,002 | (8,893) | 30,493 |
17
| Factory automation customers purchase Cognex vision products and incorporate them into
their manufacturing processes. Virtually every manufacturer can achieve better quality and
manufacturing efficiency by using machine vision, and therefore, this segment includes a
broad base of customers across a variety of industries, including automotive, consumer
electronics, food and beverage, health and beauty, medical devices, packaging,
pharmaceutical, and solar. The factory automation market also includes customers who
purchase Cognex vision products for use outside of the assembly process, such as using ID
products in logistics automation for package sorting and distribution. Sales to factory
automation customers represented approximately 74% of total revenue in the second quarter
of 2011. |
18
| Semiconductor and electronics capital equipment manufacturers purchase Cognex vision
products and integrate them into the automation equipment that they manufacture and then
sell to their customers to either make semiconductor chips or assemble printed circuit
boards. Demand from these capital equipment manufacturers has historically been highly
cyclical, with periods of investment followed by downturn. Sales to semiconductor and
electronics capital equipment manufacturers represented approximately 13% of total revenue
in the second quarter of 2011. |
||
| Surface inspection customers are manufacturers of materials processed in a continuous
fashion, such as metals, paper, non-wovens, plastics, and glass. These customers need
sophisticated machine vision to detect and classify defects on the surfaces of those
materials as they are being processed at high speeds. Surface inspection sales represented
approximately 13% of total revenue in the second quarter of 2011. |
19
20
Three-Month | Six-Month | |||||||
Period |
Period |
|||||||
MVSD RD&E expenses in 2010 |
$ | 7,162 | $ | 14,394 | ||||
Personnel-related costs |
1,096 | 2,185 | ||||||
Stock-based compensation expense |
432 | 1,002 | ||||||
Patent-related costs |
180 | 243 | ||||||
Foreign currency exchange rate changes |
212 | 162 | ||||||
Company bonus accruals |
223 | 79 | ||||||
Other |
428 | 361 | ||||||
MVSD RD&E expenses in 2011 |
$ | 9,733 | $ | 18,426 | ||||
21
Three-Month | Six-Month | |||||||
Period |
Period |
|||||||
MVSD SG&A expenses in 2010 |
$ | 18,287 | $ | 35,201 | ||||
Personnel-related costs |
2,735 | 5,353 | ||||||
Foreign currency exchange rate changes |
1,412 | 1,814 | ||||||
Stock-based compensation expense |
553 | 1,607 | ||||||
Marketing and promotional expenses |
674 | 1,387 | ||||||
Other |
(115 | ) | 472 | |||||
MVSD SG&A expenses in 2011 |
$ | 23,546 | $ | 45,834 | ||||
22
23
24
ITEM 1.
|
LEGAL PROCEEDINGS |
In May 2008, the Company filed a complaint against MvTec Software GmbH, MvTec
LLC, and Fuji America Corporation in the United States District Court for the
District of Massachusetts alleging infringement of certain patents owned by the
Company. In April 2009 and again in June 2009, Defendant MvTec Software GmbH filed
re-examination requests of the patents-at-issue with the United States Patent and
Trademark Office. This matter is ongoing. |
||
In May 2009, the Company pre-filed a complaint with the United States International
Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930, as amended,
19 U.S.C. §1337, against MvTec Software GmbH, MvTec LLC, Fuji America, and several
other respondents alleging unfair methods of competition and unfair acts in the
unlawful importation into the United States, sale for importation, or sale within the
United States after importation. By this filing, the Company requested the ITC to
investigate the Companys contention that certain machine vision software, machine
vision systems, and products containing the same infringe, and respondents directly
infringe and/or actively induce and/or contribute to the infringement in the United
States, of one or more of the Companys U.S. patents. In July 2009, the ITC issued
an order that it would institute an investigation based upon the Companys
assertions. In September 2009, the Company reached a settlement with two of the
respondents, and in December 2009, the Company reached a settlement with five
additional respondents. In March 2010, the Company reached a settlement with
respondent Fuji Machine Manufacturing Co., Ltd. and its subsidiary Fuji America
Corporation. These settlements did not have a material impact on the Companys
financial results. An ITC hearing was held in May 2010. In July 2010, the
Administrative Law Judge issued an initial determination finding two of the Companys
patents invalid and that respondents did not infringe the patents-at-issue. In
September 2010, the Commission issued a notice that it would review the initial
determination of the Administrative Law Judge. The ITC issued its Final
Determination in November 2010 in which it determined to modify-in-part and
affirm-in-part the Administrative Law Judges determination, and terminate the
investigation with a finding of no violation of Section 337 of the Tariff Act of 1930
(as amended 19 U.S.C. §1337). The Company has filed an appeal of the decision with
the United States Court of Appeals for the Federal Circuit. This matter is ongoing. |
||
The Company cannot predict the outcome of the above-referenced pending matters and an
adverse resolution of these lawsuits could have a material adverse effect on the
Companys financial position, liquidity, results of operations, and/or
indemnification obligations. In addition, various other claims and legal proceedings
generally incidental to the normal course of business are pending or threatened on
behalf of or against the Company. While we cannot predict the outcome of these
incidental matters, we believe that any liability arising from them will not have a
material adverse effect on our financial position, liquidity, or results of
operations. |
ITEM 1A.
|
RISK FACTORS |
For a complete list of factors that could affect the Companys business, results of
operations, and financial condition, see the risk factors discussion provided in Part
I - Item 1A of the Companys Annual Report on Form 10-K for the fiscal year ended
December 31, 2010. The language below has been added to an existing risk factor
previously included on Form 10-K to address the current risks associated with
international sales. |
||
Economic, political, and other risks associated with international sales and
operations could adversely affect our business and operating results. |
||
On March 11, 2011, a large earthquake hit the northeast region of Japan. While the
majority of our customers located in Japan are outside of the affected areas, certain
customers requested that orders totaling approximately $800,000, originally scheduled for March
shipment, be pushed to April. The remaining orders that were on the backlog at the
time of |
25
the earthquake, and any new orders, were fulfilled from our Cork, Ireland
distribution center. Our Koriyama, Japan distribution center suspended shipments for
approximately five weeks, but began shipping product again in April. Cognex does not
manufacture in Japan. |
||
Our key suppliers located in Japan are up and running, subject to power outages.
Cognex has a policy of maintaining strategic inventory reserves of critical
components. We have taken action to secure additional supply of
Japanese-manufactured critical parts, such as imagers. For this reason, we do not
expect significant supply disruption as a result of the earthquake. There is
uncertainty, however, regarding how demand from our customers will be impacted in the
third quarter and beyond, as the aftermath of this disaster continues to unfold
through layers of the supply chain. A decrease in demand for our products and
services, or the postponement or cancellation of orders from our customers, could
negatively impact our business and operating results. |
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
The following table sets forth information with respect to purchases by the Company of shares of its Common Stock during the periods indicated: |
Approximate | ||||||||||||||||
Total Number | Dollar Value of | |||||||||||||||
of Shares | Shares that | |||||||||||||||
Purchased as | May Yet Be | |||||||||||||||
Total | Part of Publicly | Purchased | ||||||||||||||
Number of | Announced | Under the | ||||||||||||||
Shares | Average Price | Plans or | Plans or | |||||||||||||
Purchased | Paid per Share | Programs (1) |
Programs |
|||||||||||||
April 4 May 1, 2011 |
- | - | - | $ | 30,000,000 | |||||||||||
May 2 May 29, 2011 |
- | - | - | $ | 30,000,000 | |||||||||||
May 30 July 3, 2011 |
- | - | - | $ | 30,000,000 | |||||||||||
Total |
- | - | - | $ | 30,000,000 |
(1) | In April 2008, the Companys Board of Directors authorized the
repurchase of up to $50,000,000 of the Companys common stock. |
ITEM 3.
|
DEFAULTS UPON SENIOR SECURITIES | |
None |
ITEM 4.
|
REMOVED AND RESERVED |
ITEM 5.
|
OTHER INFORMATION | |
None |
ITEM 6.
|
EXHIBITS |
26
27
Date: August 1, 2011
|
COGNEX CORPORATION | |||||
By: | /s/ Robert J. Willett
|
|||||
Robert J. Willett | ||||||
President and Chief Executive Officer | ||||||
(duly authorized officer, principal executive officer) | ||||||
By: | /s/ Richard A. Morin
|
|||||
Richard A. Morin | ||||||
Executive Vice President of Finance and Chief Financial Officer | ||||||
(duly authorized officer, principal financial and
accounting officer) |
28
1. | I have reviewed this quarterly report on Form 10-Q of Cognex Corporation; |
||
2. | Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report; |
||
3. | Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report; |
||
4. | The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared; |
||
(b) | Designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles; |
||
(c) | Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and |
||
(d) | Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most
recent fiscal quarter (the registrants fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting;
and |
5. | The registrants other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of directors
(or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and |
||
(b) | Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal control
over financial reporting. |
Date: August 1, 2011
|
By: | /s/ Robert J. Willett
|
||||
Robert J. Willett | ||||||
President and Chief Executive Officer |
29
1. | I have reviewed this quarterly report on Form 10-Q of Cognex Corporation; |
||
2. | Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report; |
||
3. | Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report; |
||
4. | The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared; |
||
(b) | Designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles; |
||
(c) | Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and |
||
(d) | Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most
recent fiscal quarter (the registrants fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting;
and |
5. | The registrants other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of directors
(or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and |
||
(b) | Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal control
over financial reporting. |
Date: August 1, 2011
|
By: | /s/ Richard A. Morin
|
||||
Executive Vice President of Finance and Chief Financial Officer |
30
Date: August 1, 2011
|
By: | /s/ Robert J. Willett
|
||||
Robert J. Willett | ||||||
President and Chief Executive Officer |
31
Date: August 1, 2011
|
By: | /s/ Richard A. Morin
|
||||
Richard A. Morin | ||||||
Executive Vice President of Finance and Chief
Financial Officer |
32
Weighted-Average Shares (Details)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2011
|
Jul. 04, 2010
|
Jul. 03, 2011
|
Jul. 04, 2010
|
|
Weighted-average common and common-equivalent shares outstanding: | ||||
Basic weighted-average common shares outstanding | 41,842,000 | 39,683,000 | 41,586,000 | 39,675,000 |
Effect of dilutive stock options | 968,000 | 110,000 | 946,000 | 61,000 |
Weighted-average common and common-equivalent shares outstanding | 42,810,000 | 39,793,000 | 42,532,000 | 39,736,000 |
Weighted-Average Shares (Textuals) [Abstract] | ||||
Antidilutive shares excluded from calculation of dilutive net income (loss) per share | 968,676 | 3,384,286 | 728,572 | 3,859,914 |
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Per Share data |
Jul. 03, 2011
|
Dec. 31, 2010
|
---|---|---|
Current assets: | ||
Reserves for accounts receivable | $ 1,248 | $ 1,235 |
Shareholders' equity: | ||
Common stock, par value | $ 0.002 | $ 0.002 |
Common stock, shares authorized | 140,000 | 140,000 |
Common stock, shares issued | 42,065 | 41,065 |
Dividends
|
6 Months Ended |
---|---|
Jul. 03, 2011
|
|
Dividends Disclosure [Abstract] | |
Dividends |
NOTE 16: Dividends
On May 2, 2011, the Company’s Board of Directors declared a cash dividend of $0.09 per share. The
dividend was paid on June 17, 2011 to all shareholders of record at the close of business on June
3, 2011.
On July 28, 2011, the Company’s Board of
Directors declared a cash dividend of $0.09 per share.
The dividend is payable on September 16, 2011 to all shareholders of record at the close of
business on September 2, 2011.
|
Document and Entity Information (USD $)
|
6 Months Ended | |
---|---|---|
Jul. 03, 2011
|
Jul. 04, 2010
|
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | COGNEX CORP | |
Entity Central Index Key | 0000851205 | |
Document Type | 10-Q | |
Document Period End Date | Jul. 03, 2011 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2011 | |
Document Fiscal Period Focus | Q2 | |
Current Fiscal Year End Date | --12-31 | |
Entity Well-known Seasoned Issuer | Yes | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Public Float | $ 617,469,419 | |
Entity Common Stock, Shares Outstanding | 42,064,561 |
Taxes (Details)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2011
|
Jul. 04, 2010
|
Jul. 03, 2011
|
Jul. 04, 2010
|
|
Reconciliation of the United States federal statutory corporate tax rate to the Company's effective tax rate or income tax provision | ||||
Income tax at federal statutory rate | 35.00% | 35.00% | 35.00% | 35.00% |
State income taxes, net of federal benefit | 1.00% | 1.00% | 1.00% | 1.00% |
Foreign tax rate differential | (13.00%) | (13.00%) | (13.00%) | (13.00%) |
Income tax provision | 23.00% | 23.00% | 23.00% | 23.00% |
Cash, Cash Equivalents and Investments (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, Cash Equivalents, and Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of cash, cash equivalents and investments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of available-for-sale investments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross unrealized losses and fair value for available-for-sale investments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effective maturity dates of available-for-sale investments |
|
Stock Repurchase Program (Details) (USD $)
|
1 Months Ended | 6 Months Ended | |
---|---|---|---|
Apr. 30, 2008
|
Jul. 03, 2011
|
Jul. 03, 2011
Common Stock [Member]
|
|
Stock Repurchase Program (Textuals) [Abstract] | |||
Repurchase of shares | 0 | ||
Maximum repurchase of common stock | $ 50,000,000 | ||
Common stock repurchased, shares | 1,038,797 | ||
Common stock repurchased, value | $ 20,000,000 |
"+ text.join( "
\n" ) +"
" + text[p] + "
\n"; } } }else{ formatted = '' + raw + '
'; } html = ''+ "\n"+''+ "\n"+''+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+' | '+ "\n"+'
'+ "\n"+' | '+ "\n"+' '+ "\n"+'
'+ "\n"+' | '+ "\n"+' '+ "\n"+'
Inventories
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories |
NOTE 5: Inventories
Inventories consisted of the following (in thousands):
|
Inventories (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories |
|
Derivative Instruments (Details)
|
Jul. 03, 2011
Japanese Yen/Euro [Member]
JPY (¥)
|
Jul. 03, 2011
Us Dollar Euro [Member]
USD ($)
|
---|---|---|
Outstanding forward contracts | ||
Outstanding forward contracts | ¥ 200,000,000 | $ 14,310,000 |
Fair Value Measurements (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and liabilities measured at fair value on a recurring basis |
|
Derivative Instruments
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments |
NOTE 10: Derivative Instruments
The Company is exposed to certain risks relating to its ongoing business operations including
foreign currency exchange rate risk and interest rate risk. The Company does not currently manage
its interest rate risk with derivative instruments; however, foreign currency exchange rate risk is
currently mitigated with derivative instruments. The Company uses derivative instruments to
provide an economic hedge against its transactional currency/functional currency exchange rate
exposures. Forward contracts on currencies are entered into to manage the transactional
currency/functional currency exposure of the Company’s Irish subsidiary’s accounts receivable
denominated in U.S. dollars and intercompany receivables denominated in Japanese Yen. These
forward contracts are used to minimize foreign currency gains or losses, as the gains or losses on
these contracts are intended to offset the losses or gains on the underlying exposures.
These forward contracts do not qualify for hedge accounting. Both the underlying exposures and the
forward contracts are recorded at fair value on the Consolidated Balance Sheets and changes in fair
value are reported as “Foreign currency gain (loss)” on the Consolidated Statements of Operations.
The Company recorded net foreign currency gains of $210,000 and $151,000 in the three-month and
six-month periods in 2011, respectively, and net foreign losses of $8,000 and $173,000 in the
three-month and six-month periods in 2010, respectively.
As of July 3, 2011, the Company had the following outstanding forward contracts that were entered
into to mitigate foreign currency exchange rate risk:
Information regarding the fair value of the forward contracts outstanding as of July 3, 2011 and
December 31, 2010 was as follows (in thousands):
Information regarding the effect of the forward contracts, net of the underlying exposure, on
the Consolidated Statements of Operations for the three-month and six-month periods ended July 3,
2011 and July 4, 2010 were as follows (in thousands):
|
Summary of Significant Accounting Policies
|
6 Months Ended |
---|---|
Jul. 03, 2011
|
|
Summary of Significant Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies |
NOTE 1: Summary of Significant Accounting Policies
As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports
on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally
accepted accounting principles (GAAP). Reference should be made to the consolidated financial
statements and related notes included in the Company’s Annual Report on Form 10-K for the year
ended December 31, 2010.
In the opinion of the management of Cognex Corporation (the “Company”), the accompanying
consolidated unaudited financial statements contain all adjustments, consisting of normal,
recurring adjustments necessary to present fairly the Company’s financial position as of July 3,
2011, and the results of its operations for the three-month and six-month periods ended July 3,
2011 and July 4, 2010, and changes in shareholders’ equity and cash flows for the periods
presented.
The results disclosed in the Consolidated Statements of Operations for the three-month and
six-month periods ended July 3, 2011 are not necessarily indicative of the results to be expected
for the full year.
|
Fair Value Measurements (Details Textual) (USD $)
In Thousands |
6 Months Ended |
---|---|
Jul. 03, 2011
|
|
Fair Value, Measurements, Recurring [Member]
|
|
Fair Value Measurements (Textuals) [Abstract] | |
Other than temporary impairment loss | $ 0 |
Fair Value, Measurements, Nonrecurring [Member]
|
|
Fair Value Measurements (Textuals) [Abstract] | |
Impairment charge | $ 0 |
Warranty Obligations
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||
Warranty Obligations and Contingencies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
Warranty Obligations |
NOTE 7: Warranty Obligations
The Company warrants its hardware products to be free from defects in material and workmanship for
periods primarily ranging from six months to two years from the time of sale based upon the product
being purchased and the terms of the customer arrangement. Warranty obligations are evaluated and
recorded at the time of sale since it is probable that customers will make claims under warranties
related to products that have been sold and the amount of these claims can be reasonably estimated
based upon historical costs to fulfill claims. Obligations may also be recorded subsequent to the
time of sale whenever specific events or circumstances impacting product quality become known that
would not have been taken into account using historical data. Warranty obligations are included in
“Accrued expenses” on the Consolidated Balance Sheets.
The changes in the warranty obligations were as follows (in thousands):
|
Stock Repurchase Program
|
6 Months Ended |
---|---|
Jul. 03, 2011
|
|
Stock Repurchase Program [Abstract] | |
Stock Repurchase Program |
NOTE 12: Stock Repurchase Program
In April 2008, the Company’s Board of Directors authorized the repurchase of up to $50,000,000 of
the Company’s common stock. As of July 3, 2011, the Company had repurchased a total of 1,038,797
shares at a cost of $20,000,000 under this program. The Company did not purchase any shares under
this program during the six-month period ended July 3, 2011. The Company may repurchase shares
under this program in future periods depending upon a variety of factors, including, among other
things, stock price levels, share availability, and cash reserve requirements.
|
Contingencies
|
6 Months Ended |
---|---|
Jul. 03, 2011
|
|
Warranty Obligations and Contingencies [Abstract] | |
Contingencies |
NOTE 8: Contingencies
In May 2008, the Company filed a complaint against MvTec Software GmbH, MvTec LLC, and Fuji America
Corporation in the United States District Court for the District of Massachusetts alleging
infringement of certain patents owned by the Company. In April 2009 and again in June 2009,
Defendant MvTec Software GmbH filed re-examination requests of the patents-at-issue with the United
States Patent and Trademark Office. This matter is ongoing.
In May 2009, the Company pre-filed a complaint with the United States International Trade
Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. §1337,
against MvTec Software GmbH, MvTec LLC, Fuji America, and several other respondents alleging unfair
methods of competition and unfair acts in the unlawful importation into the United States, sale for
importation, or sale within the United States after importation. By this filing, the Company
requested the ITC to investigate the Company’s contention that certain machine vision software,
machine vision systems, and products containing the same infringe, and respondents directly
infringe and/or actively induce and/or contribute to the infringement in the United States, of one
or more of the Company’s U.S. patents. In July 2009, the ITC issued an order that it would
institute an investigation based upon the Company’s assertions. In September 2009, the Company
reached a settlement with two of the respondents, and in December 2009, the Company reached a
settlement with five additional respondents. In March 2010, the Company reached a settlement with
respondent Fuji Machine Manufacturing Co., Ltd. and its subsidiary Fuji America Corporation. These
settlements did not have a material impact on the Company’s financial results. An ITC hearing was
held in May 2010. In July 2010, the Administrative Law Judge issued an initial determination
finding two of the Company’s patents invalid and that respondents did not infringe the
patents-at-issue. In September 2010, the Commission issued a notice that it would review the
initial determination of the Administrative Law Judge. The ITC issued its Final Determination in
November 2010 in which it determined to modify-in-part and affirm-in-part the Administrative Law
Judge’s determination, and terminate the investigation with a finding of no violation of Section
337 of the Tariff Act of 1930 (as amended 19 U.S.C. §1337). The Company has filed an appeal of the
decision with the United States Court of Appeals for the Federal Circuit. This matter is ongoing.
The Company cannot predict the outcome of the above-referenced pending matters and an adverse
resolution of these lawsuits could have a material adverse effect on the Company’s financial
position, liquidity, results of operations, and/or indemnification obligations. In addition,
various other claims and legal proceedings generally incidental to the normal course of business
are pending or threatened on behalf of or against the Company. While we cannot predict the outcome
of these incidental matters, we believe that any liability arising from them will not have a
material adverse effect on our financial position, liquidity, or results of operations.
|
R>&QG-TWGU00"4F84`0'(&WK_?7;W>`!R9*LQ)9U
MF*E4(I%$HX\?NAL@&GK[KYM1P*Z$-E*%[RK-O4:%B=!3O@P'[RJ)J7'C25GY
MU\___5]O_U&KL7\?77Q@OXA0:!X+GUW+>$C7/G+]E1VK:*SE8!BS9\?/66_,
M+B[8B0I#$01BS&JUC,@1-]!6A99::Z^9WKOIZ8`!/Z%Y5QG&<718KU]?7^_A
MY3VE!_56H[%?EZ&)>>B)BGWR,)#AUP6/X^T>])<]?G/K^>M]>KKY^O7K.MW-
M'O4&X4W^I*<&H;C9\]0(Z#:;M<;+6F,_>U(:]:+5?+F(:_M$U@`4.^`\RAOT
MN>G1P^F-M(]F;;^9,P[TY#?H!>_Z10/WX9_J]F;^J)&S-`)/-NO__OBAXPW%
MB->F._#%%'4CO+V!NJK##9=_L"QC;U&QAX8H78@^(T4?QN-(O*L8.8H")$O7
MAEKTWU50]S4DTGC9V-^[,7Z%U2TA!-"Q"F-Q$[..\&+`K84/W//2Z])_5^G(
MFX_P=6A.0U_XW<;^;TF`!+O':C128;<3*^]K]Z,8]83NMBR70$*$L8S'Z3?X
M+GV\TI=",^)>3&@J$_GX[/?*SPWX\^J@V6H VLH9WAQCJZK+HG
M+[-]-20Y46]\SZ:)T51A0F9"9D+FC)&I4[P]=%7AWU>C;?,5G4?S%:/X2-$U
MI@3NV\!+$G_A@_F;U[?0H,7>+,V\X).7HCXRK^^\%)QUNQ5#NI!XD&W$#5:*
M9/EMYP5KA5\D3?GA'U+9GY&T2F>4[INQ.&;7S5@,18RF!-,JTRK3*J*M0G],
M%+PHO>D,GWN`:]]0:>IAT!"[W3YS*Q`&5?H3>(,T,!"%%M!KPC08I%N%*$30
M+O2)"/J%,1&AP_X@)U(CV?GLTW:56:HFNW:?F=>MH&TQO+-O4$=363@:0%5=
MMNR.)_5TH`!$'M#J6+*BC6)`JZ;+CC,*2&W9MD8!J+K.$Q`=4-61;?;QB722
MWWN6LKC5Q)8C&]HHQG1IBNSTZ;VTX&%+-HQ1C)H?10JRJIBRS5Z*-)@S(&X!
MK-YO"74;:R"[3H]%:.R0ZK*BC`+048B\#JT2N[\BI!,@=*VG*JMFCZ=M=D@-
MV;!'X<>:LCOI`WX62Y5-G9E!!_,`Q"U/',6N]UQ[=N+4'`60PD\$GBKS)CPF
M/"8\VJFD88\BW>JI/44EF]>W/\1>:*(IFJRH&LU7NC)>_2!J.;*E&Z>/IZ[+
MJFJ?/I[J8(6;_6[G-*-Y[YZ4B"AFF<>$S(3,A$Q[7=7CP.DV-3!MBZ&,5L50
M)OF(6BV&NI\]@WD6@)L%PBU,H_CU;1;'\%_G6?A4T*E4^$1+HO$7.6V[`-V/
MD;:[KERR&6HD-%$K,?IYY=RK2JB'YNC;[CC4@Z^2+O,\=QP)RCLP`\M'$$NZ
M*G=_%AB.[(S%%E#+#[0Y1P$,X>2:G-M5_G]!1?QVX(5_2?=0^8/RB]M@"WA$
MG)X;25CUSOLJ+='07^C/]%+\L58;]9&;#H)6MNS88@3GCD.9$E'5D&WVJA,Z
MINR`\?Z(XK_@;R]6<30#B5B)!AO3)MN6.03KL,.NR0I[5I20*NJ#'_H)/"A*
M3U$D6$;*FE$L6;<&N=!AA]V$:G'*6J!R0(6XE3T5/.@MSN0$G]YS@_D;@^4/
MM/->-7N=HS^\]WJ,&P)=)Y5Y&,F)FA=>JGFZT6)EHAYOM&@O-YAOKZH73TRW
M,O;!VZO;.)IGL_0/+XZ],'W]Z'N/?N"GK^=YBV7ON\6B(]6(;[/(?52-,AV@
M.Y_M='W'Y3ABW-CTL\IA=3G:%C=O/'B"@(<'+Y&BA53E7+K=#"N746+Q'/$!5A;6POB*@L3DZZ-9KX;JM"5G\M)*
M]I&-\)@NW(^?ED;,VODKPRN1%
HO/`I(DO
[#>!I#\QU%ES?$=7/Y:O(9UTJ.H1E>T^R_7&FZ5%^L(E'=
MUCYD]2B*48]3J_N@HS.0HAZ@CL3I""72+%%Y*_H=@2C$ZCQ%0M4GB=CYH*KM
MZ07>@A:''1\![]:+FOR&>W49I_KE?ZU)Q91+Z:ET&8WKYA>'TP'KQSGAY8J[
M_,I?C>(*G]=8AVW?J.$&W^%V?]_Y](;IGEY0P(3%9;JG/QW`^-W3.T*>NK=\
MGR+P`\T/C1/$"83R#><6.%?KXM%?<5G`1UP6T!]@)T2;4^+289BA<2?NP"QZ
M"B'Q<,G3=4B:?_49/#TIZIP2IVZ0'V@KV$+IPV1@#3!DA=W/.>SZ`>0/$#@WB#/'J]W
M@B:>CICE4>(\Z=AL\0_,G1W:WJ^O-3?WYIU7=#@*EXJ.NLO+?`6;(46>H7*#
M895^
R=R.Y\IVP`VC*!AP+%G11L8.M@F/
MZ!T/[.X[_#:&"@'+D0UM9`=>W8"'](YC(QWP@_@E`9H.F<$9%S.HYMKVG8KB
M&$41@*K*JLGUSJ\'7G%EG7NL?3K93N&R06W.WGJBYRA.+U(0+\M33\34*)JB
MR8HZLFL:U;!E1YNB9?QE<8J6\=,JZ"]3M.RTGA/2=1U#M,QR1^:V\K[@G<)D
M>.MU=#?'H<=`G\#KAFQW'3:=PF0UO&++NCJRD*INR;;%//%T,-TA?IA,-637
M&5F83%-E16,>W"ZDXAA'F$R1]7RP^VAX97S^Q@@:8W!J,-$G[+IL&NI)J8R/
M_M)'G;)77IR&($Z>_1495XPFI?V8CU^`?R=SB]&X!C1&65J"]#F:_R0F8YFR
MJX^L%'H#,C_&FD)F4QA^4/NT+PS_,0J?1A*%5Q74M7%D'HN*K@Y,WN[MI%*F
M*/Q('9UN.6I/`2"%VM@79C%U>%P:Y&A=4^-W!`::H\N*P]M9'KL"$EYV3PJ9
M.B;JH2E0V_8OS/U_JJU[VO2QT:K3\:Y>/#]`?_D0Q?<0B7O4P0AW-3K75C]:
M:>8=!76F279"]?0QM>/;S1BC[8,SX3+ATC4N]#[;0$U_1'^.NL>/MGU(^#6.
M$JYC]B:`M6[/PN+(!.L67BVC.(60S\>PC070OX4Q@(].4$\BTP]%V'K'O8V2
M5/"M9D/L5\\/1=?[;)A]A`8-G"9JJ*.QA%L:MT>O3K9/9,KGIK!D:A<_/2?V
M